In silico analyses and SMYD2 protein expression patterns in ESCC, HCC, and breast cancer primary tumors and/or cell lines suggest that these tumor types may be potentially driven by SMYD2. The gene discussed is SMYD2; the disease is esophageal squamous cell carcinoma.